Triglyceride–glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies
Background Insulin resistance has been demonstrated to be involved in the pathogenesis of atherosclerotic cardiovascular diseases (ASCVDs). This study evaluated the association between the triglyceride–glucose (TyG) index, a novel surrogate indicator of insulin resistance, and the incidence of ASCVD...
Saved in:
| Published in: | Cardiovascular diabetology Vol. 20; no. 1; pp. 76 - 13 |
|---|---|
| Main Authors: | , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
London
BioMed Central
03.04.2021
Springer Nature B.V BMC |
| Subjects: | |
| ISSN: | 1475-2840, 1475-2840 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Background
Insulin resistance has been demonstrated to be involved in the pathogenesis of atherosclerotic cardiovascular diseases (ASCVDs). This study evaluated the association between the triglyceride–glucose (TyG) index, a novel surrogate indicator of insulin resistance, and the incidence of ASCVDs in people without ASCVDs at baseline by performing a meta-analysis.
Methods
Cohort studies reporting the multivariate-adjusted association between the TyG index and the incidence of ASCVDs were obtained by searching the PubMed and Embase databases. A random-effects model incorporating intra-study heterogeneity was applied to combine the results.
Results
Eight cohort studies comprising 5,731,294 participants were included in this meta-analysis. The results showed that compared to those with the lowest TyG index category, participants with the highest TyG index category were independently associated with a higher risk of ASCVDs [hazard ratio (HR): 1.61, 95% confidence interval (CI) 1.29–2.01, I
2
= 80%, P < 0.001]. This finding was consistent with the meta-analysis results with the TyG index analyzed as a continuous variable (HR per 1-unit increment of the TyG index: 1.39, 95% CI 1.18–1.64, I
2
= 89%, P < 0.001). Subgroup analyses suggested that the age, sex, and diabetic status did not significantly affect the association (for subgroup analyses, all P > 0.05). Moreover, participants with the highest TyG index category were independently associated with a higher risk of coronary artery disease [(CAD), HR: 1.95, 95% CI 1.47–2.58, I
2
= 92%, P < 0.001] and stroke (HR: 1.26, 95% CI 1.23–1.29, I
2
= 0%, P < 0.001).
Conclusions
A higher TyG index may be independently associated with a higher incidence of ASCVDs, CAD, and stroke in people without ASCVDs at baseline. |
|---|---|
| AbstractList | Insulin resistance has been demonstrated to be involved in the pathogenesis of atherosclerotic cardiovascular diseases (ASCVDs). This study evaluated the association between the triglyceride-glucose (TyG) index, a novel surrogate indicator of insulin resistance, and the incidence of ASCVDs in people without ASCVDs at baseline by performing a meta-analysis.BACKGROUNDInsulin resistance has been demonstrated to be involved in the pathogenesis of atherosclerotic cardiovascular diseases (ASCVDs). This study evaluated the association between the triglyceride-glucose (TyG) index, a novel surrogate indicator of insulin resistance, and the incidence of ASCVDs in people without ASCVDs at baseline by performing a meta-analysis.Cohort studies reporting the multivariate-adjusted association between the TyG index and the incidence of ASCVDs were obtained by searching the PubMed and Embase databases. A random-effects model incorporating intra-study heterogeneity was applied to combine the results.METHODSCohort studies reporting the multivariate-adjusted association between the TyG index and the incidence of ASCVDs were obtained by searching the PubMed and Embase databases. A random-effects model incorporating intra-study heterogeneity was applied to combine the results.Eight cohort studies comprising 5,731,294 participants were included in this meta-analysis. The results showed that compared to those with the lowest TyG index category, participants with the highest TyG index category were independently associated with a higher risk of ASCVDs [hazard ratio (HR): 1.61, 95% confidence interval (CI) 1.29-2.01, I2 = 80%, P < 0.001]. This finding was consistent with the meta-analysis results with the TyG index analyzed as a continuous variable (HR per 1-unit increment of the TyG index: 1.39, 95% CI 1.18-1.64, I2 = 89%, P < 0.001). Subgroup analyses suggested that the age, sex, and diabetic status did not significantly affect the association (for subgroup analyses, all P > 0.05). Moreover, participants with the highest TyG index category were independently associated with a higher risk of coronary artery disease [(CAD), HR: 1.95, 95% CI 1.47-2.58, I2 = 92%, P < 0.001] and stroke (HR: 1.26, 95% CI 1.23-1.29, I2 = 0%, P < 0.001).RESULTSEight cohort studies comprising 5,731,294 participants were included in this meta-analysis. The results showed that compared to those with the lowest TyG index category, participants with the highest TyG index category were independently associated with a higher risk of ASCVDs [hazard ratio (HR): 1.61, 95% confidence interval (CI) 1.29-2.01, I2 = 80%, P < 0.001]. This finding was consistent with the meta-analysis results with the TyG index analyzed as a continuous variable (HR per 1-unit increment of the TyG index: 1.39, 95% CI 1.18-1.64, I2 = 89%, P < 0.001). Subgroup analyses suggested that the age, sex, and diabetic status did not significantly affect the association (for subgroup analyses, all P > 0.05). Moreover, participants with the highest TyG index category were independently associated with a higher risk of coronary artery disease [(CAD), HR: 1.95, 95% CI 1.47-2.58, I2 = 92%, P < 0.001] and stroke (HR: 1.26, 95% CI 1.23-1.29, I2 = 0%, P < 0.001).A higher TyG index may be independently associated with a higher incidence of ASCVDs, CAD, and stroke in people without ASCVDs at baseline.CONCLUSIONSA higher TyG index may be independently associated with a higher incidence of ASCVDs, CAD, and stroke in people without ASCVDs at baseline. Insulin resistance has been demonstrated to be involved in the pathogenesis of atherosclerotic cardiovascular diseases (ASCVDs). This study evaluated the association between the triglyceride-glucose (TyG) index, a novel surrogate indicator of insulin resistance, and the incidence of ASCVDs in people without ASCVDs at baseline by performing a meta-analysis. Cohort studies reporting the multivariate-adjusted association between the TyG index and the incidence of ASCVDs were obtained by searching the PubMed and Embase databases. A random-effects model incorporating intra-study heterogeneity was applied to combine the results. Eight cohort studies comprising 5,731,294 participants were included in this meta-analysis. The results showed that compared to those with the lowest TyG index category, participants with the highest TyG index category were independently associated with a higher risk of ASCVDs [hazard ratio (HR): 1.61, 95% confidence interval (CI) 1.29-2.01, I = 80%, P < 0.001]. This finding was consistent with the meta-analysis results with the TyG index analyzed as a continuous variable (HR per 1-unit increment of the TyG index: 1.39, 95% CI 1.18-1.64, I = 89%, P < 0.001). Subgroup analyses suggested that the age, sex, and diabetic status did not significantly affect the association (for subgroup analyses, all P > 0.05). Moreover, participants with the highest TyG index category were independently associated with a higher risk of coronary artery disease [(CAD), HR: 1.95, 95% CI 1.47-2.58, I = 92%, P < 0.001] and stroke (HR: 1.26, 95% CI 1.23-1.29, I = 0%, P < 0.001). A higher TyG index may be independently associated with a higher incidence of ASCVDs, CAD, and stroke in people without ASCVDs at baseline. Background Insulin resistance has been demonstrated to be involved in the pathogenesis of atherosclerotic cardiovascular diseases (ASCVDs). This study evaluated the association between the triglyceride–glucose (TyG) index, a novel surrogate indicator of insulin resistance, and the incidence of ASCVDs in people without ASCVDs at baseline by performing a meta-analysis. Methods Cohort studies reporting the multivariate-adjusted association between the TyG index and the incidence of ASCVDs were obtained by searching the PubMed and Embase databases. A random-effects model incorporating intra-study heterogeneity was applied to combine the results. Results Eight cohort studies comprising 5,731,294 participants were included in this meta-analysis. The results showed that compared to those with the lowest TyG index category, participants with the highest TyG index category were independently associated with a higher risk of ASCVDs [hazard ratio (HR): 1.61, 95% confidence interval (CI) 1.29–2.01, I2 = 80%, P < 0.001]. This finding was consistent with the meta-analysis results with the TyG index analyzed as a continuous variable (HR per 1-unit increment of the TyG index: 1.39, 95% CI 1.18–1.64, I2 = 89%, P < 0.001). Subgroup analyses suggested that the age, sex, and diabetic status did not significantly affect the association (for subgroup analyses, all P > 0.05). Moreover, participants with the highest TyG index category were independently associated with a higher risk of coronary artery disease [(CAD), HR: 1.95, 95% CI 1.47–2.58, I2 = 92%, P < 0.001] and stroke (HR: 1.26, 95% CI 1.23–1.29, I2 = 0%, P < 0.001). Conclusions A higher TyG index may be independently associated with a higher incidence of ASCVDs, CAD, and stroke in people without ASCVDs at baseline. Background Insulin resistance has been demonstrated to be involved in the pathogenesis of atherosclerotic cardiovascular diseases (ASCVDs). This study evaluated the association between the triglyceride–glucose (TyG) index, a novel surrogate indicator of insulin resistance, and the incidence of ASCVDs in people without ASCVDs at baseline by performing a meta-analysis. Methods Cohort studies reporting the multivariate-adjusted association between the TyG index and the incidence of ASCVDs were obtained by searching the PubMed and Embase databases. A random-effects model incorporating intra-study heterogeneity was applied to combine the results. Results Eight cohort studies comprising 5,731,294 participants were included in this meta-analysis. The results showed that compared to those with the lowest TyG index category, participants with the highest TyG index category were independently associated with a higher risk of ASCVDs [hazard ratio (HR): 1.61, 95% confidence interval (CI) 1.29–2.01, I 2 = 80%, P < 0.001]. This finding was consistent with the meta-analysis results with the TyG index analyzed as a continuous variable (HR per 1-unit increment of the TyG index: 1.39, 95% CI 1.18–1.64, I 2 = 89%, P < 0.001). Subgroup analyses suggested that the age, sex, and diabetic status did not significantly affect the association (for subgroup analyses, all P > 0.05). Moreover, participants with the highest TyG index category were independently associated with a higher risk of coronary artery disease [(CAD), HR: 1.95, 95% CI 1.47–2.58, I 2 = 92%, P < 0.001] and stroke (HR: 1.26, 95% CI 1.23–1.29, I 2 = 0%, P < 0.001). Conclusions A higher TyG index may be independently associated with a higher incidence of ASCVDs, CAD, and stroke in people without ASCVDs at baseline. Abstract Background Insulin resistance has been demonstrated to be involved in the pathogenesis of atherosclerotic cardiovascular diseases (ASCVDs). This study evaluated the association between the triglyceride–glucose (TyG) index, a novel surrogate indicator of insulin resistance, and the incidence of ASCVDs in people without ASCVDs at baseline by performing a meta-analysis. Methods Cohort studies reporting the multivariate-adjusted association between the TyG index and the incidence of ASCVDs were obtained by searching the PubMed and Embase databases. A random-effects model incorporating intra-study heterogeneity was applied to combine the results. Results Eight cohort studies comprising 5,731,294 participants were included in this meta-analysis. The results showed that compared to those with the lowest TyG index category, participants with the highest TyG index category were independently associated with a higher risk of ASCVDs [hazard ratio (HR): 1.61, 95% confidence interval (CI) 1.29–2.01, I2 = 80%, P < 0.001]. This finding was consistent with the meta-analysis results with the TyG index analyzed as a continuous variable (HR per 1-unit increment of the TyG index: 1.39, 95% CI 1.18–1.64, I2 = 89%, P < 0.001). Subgroup analyses suggested that the age, sex, and diabetic status did not significantly affect the association (for subgroup analyses, all P > 0.05). Moreover, participants with the highest TyG index category were independently associated with a higher risk of coronary artery disease [(CAD), HR: 1.95, 95% CI 1.47–2.58, I2 = 92%, P < 0.001] and stroke (HR: 1.26, 95% CI 1.23–1.29, I2 = 0%, P < 0.001). Conclusions A higher TyG index may be independently associated with a higher incidence of ASCVDs, CAD, and stroke in people without ASCVDs at baseline. |
| ArticleNumber | 76 |
| Author | Wu, Jing Ding, Xiaobo Wang, Xiaozhen Cui, Meizi Zhang, Manli |
| Author_xml | – sequence: 1 givenname: Xiaobo surname: Ding fullname: Ding, Xiaobo organization: Radiology Department, The First Hospital of Jilin University – sequence: 2 givenname: Xiaozhen surname: Wang fullname: Wang, Xiaozhen organization: Department of Breast Surgery, The First Hospital of Jilin University – sequence: 3 givenname: Jing surname: Wu fullname: Wu, Jing organization: Department of General Practice, The First Hospital of Jilin University – sequence: 4 givenname: Manli surname: Zhang fullname: Zhang, Manli organization: Department of Hepatology and Gastroenterology, The Second Part of First Hospital, Jilin University – sequence: 5 givenname: Meizi surname: Cui fullname: Cui, Meizi email: chlalwk@jlu.edu.cn organization: Department of Cadre Ward, The First Hospital of Jilin University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33812373$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9Ustu1TAQjVARfcAPsECR2LAJ2OPEcVggoYpHpUpsytqa2JN7XfnGxU6qXokF_8Af8iU4vS20XdQLP2bOOTPjmcNibwwjFcVLzt5yruS7xKETomLAK8ZBqqp7Uhzwum0qUDXbu3PfLw5TOmeMt0ryZ8W-EIqDaMVB8fMsupXfGorO0p9fv1d-NiFR6UZLVyWOtpzWy8tk92ioDEOJ2RJDMj7vkzOlwWhduMRkZo-xtC4RJkrvSyw3NGGFI_ptcmnhmrAOcSrTNFtH6XnxdECf6MXNeVR8__zp7Phrdfrty8nxx9PKyFZMVW96YDWBZSAHYSWTwJUFhWwgGKi10EguB6uoh1opK6G2jcWealWDhVYcFSc7XRvwXF9Et8G41QGdvjaEuNIYcymeNONmkGQ63rKuzgHQ8hxZdEPPDWsam7U-7LQu5n5D1tA4RfT3RO97RrfWq3CpFeNdw3gWeHMjEMOPmdKkNy4Z8h5HCnPS0DCVF4g6Q18_gJ6HOebvXFC8BgmSL9W9upvRv1Rum5wBagcwuW0p0qCNm3ByYUnQec2ZXuZJ7-ZJ53nS1_Oku0yFB9Rb9UdJYkdKGTyuKP5P-xHWX04c4Jc |
| CitedBy_id | crossref_primary_10_3389_fcvm_2022_895609 crossref_primary_10_1186_s12891_023_06700_7 crossref_primary_10_1016_j_vhri_2023_05_001 crossref_primary_10_1038_s41598_024_81967_x crossref_primary_10_1186_s12933_024_02124_2 crossref_primary_10_3389_fmed_2024_1328601 crossref_primary_10_1186_s12933_024_02437_2 crossref_primary_10_3389_fcvm_2021_704462 crossref_primary_10_1016_j_annepidem_2025_08_022 crossref_primary_10_1016_j_diabres_2025_112414 crossref_primary_10_1007_s10554_024_03048_4 crossref_primary_10_1007_s12020_024_04037_2 crossref_primary_10_1186_s12890_025_03738_2 crossref_primary_10_3389_fcvm_2022_1002030 crossref_primary_10_2147_DMSO_S526411 crossref_primary_10_1111_jog_16283 crossref_primary_10_3389_fendo_2022_889379 crossref_primary_10_1093_eurjpc_zwad340 crossref_primary_10_1186_s12933_023_02001_4 crossref_primary_10_3389_fcvm_2022_832491 crossref_primary_10_1016_j_ecoenv_2025_118239 crossref_primary_10_1186_s12933_023_01864_x crossref_primary_10_7759_cureus_35532 crossref_primary_10_7759_cureus_65546 crossref_primary_10_3389_fendo_2024_1423227 crossref_primary_10_3389_fcvm_2023_1275710 crossref_primary_10_1007_s00417_024_06376_2 crossref_primary_10_3389_fendo_2025_1508667 crossref_primary_10_3390_jcm11216419 crossref_primary_10_3389_fcvm_2024_1517437 crossref_primary_10_1186_s12967_023_04159_7 crossref_primary_10_1186_s12933_022_01617_2 crossref_primary_10_1111_1753_0407_13312 crossref_primary_10_2196_47095 crossref_primary_10_1155_2022_5125884 crossref_primary_10_1007_s12012_024_09913_x crossref_primary_10_1055_a_1853_9889 crossref_primary_10_1186_s12902_022_01180_7 crossref_primary_10_1016_j_jdiacomp_2023_108516 crossref_primary_10_1186_s12933_023_01739_1 crossref_primary_10_3389_fendo_2022_817176 crossref_primary_10_3390_jcm14113940 crossref_primary_10_3389_fcvm_2022_994329 crossref_primary_10_1186_s12933_023_02082_1 crossref_primary_10_1186_s12933_023_02100_2 crossref_primary_10_3389_fendo_2024_1416234 crossref_primary_10_1177_10742484231181846 crossref_primary_10_1016_j_numecd_2023_10_036 crossref_primary_10_7717_peerj_18781 crossref_primary_10_7759_cureus_39034 crossref_primary_10_1016_j_surg_2024_07_034 crossref_primary_10_1186_s12933_022_01704_4 crossref_primary_10_1089_dtom_2025_0002 crossref_primary_10_3389_fendo_2024_1357580 crossref_primary_10_3390_ijms26010334 crossref_primary_10_1186_s12933_022_01694_3 crossref_primary_10_1186_s12933_022_01546_0 crossref_primary_10_1093_ckj_sfac084 crossref_primary_10_1186_s12877_024_05002_4 crossref_primary_10_3389_fendo_2022_1023867 crossref_primary_10_1186_s12933_022_01523_7 crossref_primary_10_1186_s12933_024_02510_w crossref_primary_10_1186_s12888_022_04434_9 crossref_primary_10_1038_s41598_024_75887_z crossref_primary_10_1093_eurjpc_zwac058 crossref_primary_10_1210_clinem_dgad089 crossref_primary_10_1007_s11325_024_03220_z crossref_primary_10_1177_03000605231164548 crossref_primary_10_1016_j_avsg_2023_08_013 crossref_primary_10_1186_s12933_023_01906_4 crossref_primary_10_1186_s12933_022_01453_4 crossref_primary_10_1007_s00592_024_02322_0 crossref_primary_10_1177_10815589231152823 crossref_primary_10_1093_ckj_sfac073 crossref_primary_10_1186_s12933_023_01823_6 crossref_primary_10_3389_fendo_2024_1437711 crossref_primary_10_1186_s12933_025_02854_x crossref_primary_10_1186_s12933_024_02165_7 crossref_primary_10_1155_2023_1966680 crossref_primary_10_1186_s12933_024_02241_y crossref_primary_10_3389_fcvm_2023_1242035 crossref_primary_10_1186_s12877_023_03788_3 crossref_primary_10_1111_eci_70013 crossref_primary_10_1007_s10792_024_03344_x crossref_primary_10_1186_s12933_022_01695_2 crossref_primary_10_1055_a_2266_1503 crossref_primary_10_1177_00033197221124763 crossref_primary_10_1186_s12933_025_02827_0 crossref_primary_10_3390_jcm11164644 crossref_primary_10_1038_s41598_025_09482_1 crossref_primary_10_1186_s12933_023_02110_0 crossref_primary_10_3389_fcvm_2025_1583944 crossref_primary_10_3389_fneur_2025_1626196 crossref_primary_10_1186_s12944_023_01925_w crossref_primary_10_5334_gh_1303 crossref_primary_10_1186_s12889_025_22085_9 crossref_primary_10_1186_s12933_025_02880_9 crossref_primary_10_1007_s10067_024_06884_w crossref_primary_10_1186_s12933_022_01683_6 crossref_primary_10_1186_s12933_023_02080_3 crossref_primary_10_1038_s41598_023_33294_w crossref_primary_10_26599_1671_5411_2023_03_001 crossref_primary_10_1186_s12933_021_01342_2 crossref_primary_10_1055_a_2354_3573 crossref_primary_10_1186_s12933_022_01658_7 crossref_primary_10_3389_fcvm_2025_1583614 crossref_primary_10_1186_s12933_024_02457_y crossref_primary_10_3389_fendo_2025_1542190 crossref_primary_10_1016_j_diabres_2021_109073 crossref_primary_10_3389_fendo_2023_1302127 crossref_primary_10_2147_CLEP_S457054 crossref_primary_10_1016_j_bbrc_2022_06_082 crossref_primary_10_1186_s12902_025_01834_2 crossref_primary_10_1186_s12933_023_01883_8 crossref_primary_10_3389_fcvm_2024_1396865 crossref_primary_10_1055_a_2279_7112 crossref_primary_10_2147_JHC_S454037 crossref_primary_10_1186_s13098_024_01423_8 crossref_primary_10_1016_j_cjco_2025_01_005 crossref_primary_10_3389_fendo_2022_1015747 crossref_primary_10_1186_s12933_023_01939_9 crossref_primary_10_1186_s12933_023_02054_5 crossref_primary_10_1097_MD_0000000000033194 crossref_primary_10_1186_s12872_024_04450_5 crossref_primary_10_3389_fendo_2023_1282675 crossref_primary_10_3389_fendo_2024_1290226 crossref_primary_10_3389_fendo_2025_1510493 crossref_primary_10_1186_s12933_025_02693_w crossref_primary_10_1186_s40001_025_03001_8 crossref_primary_10_3389_fcvm_2024_1429993 crossref_primary_10_1186_s12933_023_02089_8 crossref_primary_10_1186_s12933_023_01834_3 crossref_primary_10_3389_fnut_2025_1539969 crossref_primary_10_1186_s12872_025_04803_8 crossref_primary_10_1016_j_numecd_2023_02_005 crossref_primary_10_1186_s12889_024_20551_4 crossref_primary_10_1186_s12933_025_02585_z crossref_primary_10_3389_fendo_2024_1444800 crossref_primary_10_3389_fnut_2025_1452512 crossref_primary_10_1186_s13098_023_01181_z crossref_primary_10_1186_s12933_025_02668_x crossref_primary_10_1016_j_numecd_2025_104127 crossref_primary_10_1186_s12933_022_01599_1 crossref_primary_10_1186_s12933_025_02584_0 crossref_primary_10_1002_ehf2_14679 crossref_primary_10_1177_10760296221094030 crossref_primary_10_1186_s12933_025_02683_y crossref_primary_10_1111_cen_15171 crossref_primary_10_1016_j_amepre_2025_01_022 crossref_primary_10_1186_s12933_021_01332_4 crossref_primary_10_3389_fendo_2023_1187381 crossref_primary_10_1038_s41387_024_00295_1 crossref_primary_10_1186_s12933_023_02113_x crossref_primary_10_4239_wjd_v15_i6_1242 crossref_primary_10_1161_JAHA_123_030022 crossref_primary_10_3390_biomedicines13061291 crossref_primary_10_1016_j_numecd_2025_103963 crossref_primary_10_1186_s12933_022_01541_5 crossref_primary_10_1186_s12933_024_02193_3 crossref_primary_10_1097_MD_0000000000043897 crossref_primary_10_1186_s12944_022_01732_9 crossref_primary_10_3389_fendo_2023_1259062 crossref_primary_10_1016_j_ahj_2022_02_014 crossref_primary_10_1038_s41598_025_09726_0 crossref_primary_10_1186_s12933_024_02230_1 crossref_primary_10_1016_j_ijcrp_2024_200250 crossref_primary_10_1186_s12933_024_02423_8 crossref_primary_10_3389_fmed_2025_1584674 crossref_primary_10_17816_brmma677239 crossref_primary_10_4236_jbm_2025_139026 crossref_primary_10_1002_VIW_20240059 crossref_primary_10_1038_s41598_023_41546_y crossref_primary_10_3389_fcvm_2021_774781 crossref_primary_10_3389_fcvm_2024_1397907 crossref_primary_10_3390_metabo15090613 crossref_primary_10_1097_MD_0000000000039256 crossref_primary_10_3389_fendo_2022_1077632 crossref_primary_10_1186_s12933_025_02641_8 crossref_primary_10_2147_IJWH_S387942 crossref_primary_10_3390_nu17091462 crossref_primary_10_1111_odi_14420 crossref_primary_10_1038_s41598_024_84278_3 crossref_primary_10_1186_s12944_025_02508_7 crossref_primary_10_1038_s41598_025_17315_4 crossref_primary_10_3389_fcvm_2022_1019233 crossref_primary_10_1097_GME_0000000000002374 crossref_primary_10_1016_j_numecd_2022_11_004 crossref_primary_10_1038_s41598_024_78056_4 crossref_primary_10_1186_s12933_023_02115_9 crossref_primary_10_2147_IJGM_S350474 crossref_primary_10_3390_jcm14030950 crossref_primary_10_1186_s12902_025_01900_9 crossref_primary_10_1186_s12933_024_02390_0 crossref_primary_10_3389_fendo_2021_761397 crossref_primary_10_1186_s12933_022_01472_1 crossref_primary_10_2147_DMSO_S385906 crossref_primary_10_1186_s13098_024_01306_y crossref_primary_10_1055_a_1766_0202 crossref_primary_10_1186_s12944_024_02394_5 crossref_primary_10_1007_s12291_022_01083_3 crossref_primary_10_1186_s12933_024_02392_y crossref_primary_10_1186_s12986_024_00802_2 crossref_primary_10_1186_s12890_025_03869_6 crossref_primary_10_1186_s12933_023_02038_5 crossref_primary_10_1177_20420188251328840 crossref_primary_10_3389_fcvm_2022_1035105 crossref_primary_10_1007_s11357_023_01044_5 crossref_primary_10_1186_s12933_023_02016_x crossref_primary_10_3389_fonc_2025_1532253 crossref_primary_10_1186_s12933_025_02872_9 crossref_primary_10_3389_fnut_2024_1475204 crossref_primary_10_1161_HYPERTENSIONAHA_124_23087 crossref_primary_10_1186_s12933_022_01649_8 crossref_primary_10_1186_s12872_025_04977_1 crossref_primary_10_1186_s12944_023_01773_8 crossref_primary_10_3389_fcvm_2024_1363049 crossref_primary_10_3390_metabo14120651 crossref_primary_10_1016_j_diabres_2024_111640 crossref_primary_10_3389_fendo_2024_1471535 crossref_primary_10_1136_bmjopen_2023_081131 crossref_primary_10_1186_s12944_025_02486_w crossref_primary_10_1186_s13098_025_01812_7 crossref_primary_10_1186_s12933_023_01870_z crossref_primary_10_3390_diagnostics15040494 crossref_primary_10_1111_jch_14758 crossref_primary_10_1186_s12933_023_01779_7 crossref_primary_10_3389_fendo_2023_1148203 crossref_primary_10_1038_s41598_025_93922_5 crossref_primary_10_1186_s12933_023_02004_1 |
| Cites_doi | 10.1007/s11886-020-01332-y 10.1038/s41598-019-43776-5 10.3390/nu11112838 10.1016/j.arcmed.2015.06.006 10.1186/s12933-019-0982-2 10.12997/jla.2019.8.2.173 10.1210/jc.2010-0288 10.1210/er.2018-00141 10.1186/s12933-020-01210-5 10.1186/s12933-020-01108-2 10.1186/s12944-016-0324-2 10.1089/met.2008.0034 10.1016/j.numecd.2016.12.002 10.1186/s12933-020-01121-5 10.1136/bmj.315.7109.629 10.1016/j.ctim.2020.102531 10.1097/01.hjh.0000194121.19851.e5 10.1111/1753-0407.12970 10.1186/s12916-020-01824-2 10.1186/s12872-020-01496-z 10.1016/j.diabres.2011.05.030 10.1111/j.0894-0959.2004.17311.x 10.1161/JAHA.119.012178 10.1111/eci.12583 10.1038/nrcardio.2009.55 10.2174/1573399810666140214093600 10.1007/s11883-020-00862-8 10.1186/s13098-018-0376-8 10.1001/jama.283.15.2008 10.1007/s11892-019-1178-6 10.1016/j.numecd.2019.09.015 10.1016/j.cmet.2011.07.015 10.1186/s12933-020-01186-2 10.1002/sim.1186 10.1046/j.1464-5491.2003.00869.x 10.1093/ije/dyn065 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2021 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2021 – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION NPM 3V. 7T5 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM DOA |
| DOI | 10.1186/s12933-021-01268-9 |
| DatabaseName | Springer Nature OA Free Journals CrossRef PubMed ProQuest Central (Corporate) Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1475-2840 |
| EndPage | 13 |
| ExternalDocumentID | oai_doaj_org_article_01cf6ec917094a0fad14e239fb1c055d PMC8019501 33812373 10_1186_s12933_021_01268_9 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: Research Fund of the First Hospital of Jilin University grantid: 04020940001 – fundername: ; grantid: 04020940001 |
| GroupedDBID | --- 0R~ 29B 2WC 53G 5GY 5VS 6J9 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML ABDBF ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB AAYXX AFFHD CITATION -5E -5G -A0 -BR 3V. ACRMQ ADINQ ALIPV C24 FRP NPM 7T5 7XB 8FK AZQEC DWQXO H94 K9. PKEHL PQEST PQUKI 7X8 5PM |
| ID | FETCH-LOGICAL-c673t-bcb204e2d026f3d606218d28a0fe2fe7d25616fd8eb2488d624d5dabe4842d273 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 270 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000636718400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1475-2840 |
| IngestDate | Fri Oct 03 12:42:25 EDT 2025 Tue Nov 04 01:52:02 EST 2025 Sun Nov 09 09:48:24 EST 2025 Sat Oct 11 13:41:12 EDT 2025 Thu Jan 02 22:56:53 EST 2025 Sat Nov 29 06:27:41 EST 2025 Tue Nov 18 21:18:20 EST 2025 Sat Sep 06 07:28:51 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Triglyceride-glucose index Atherosclerotic cardiovascular diseases Insulin resistance Coronary artery disease Meta-analysis |
| Language | English |
| License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c673t-bcb204e2d026f3d606218d28a0fe2fe7d25616fd8eb2488d624d5dabe4842d273 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://doaj.org/article/01cf6ec917094a0fad14e239fb1c055d |
| PMID | 33812373 |
| PQID | 2514262617 |
| PQPubID | 42570 |
| PageCount | 13 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_01cf6ec917094a0fad14e239fb1c055d pubmedcentral_primary_oai_pubmedcentral_nih_gov_8019501 proquest_miscellaneous_2508888234 proquest_journals_2514262617 pubmed_primary_33812373 crossref_citationtrail_10_1186_s12933_021_01268_9 crossref_primary_10_1186_s12933_021_01268_9 springer_journals_10_1186_s12933_021_01268_9 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-04-03 |
| PublicationDateYYYYMMDD | 2021-04-03 |
| PublicationDate_xml | – month: 04 year: 2021 text: 2021-04-03 day: 03 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Cardiovascular diabetology |
| PublicationTitleAbbrev | Cardiovasc Diabetol |
| PublicationTitleAlternate | Cardiovasc Diabetol |
| PublicationYear | 2021 |
| Publisher | BioMed Central Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: Springer Nature B.V – name: BMC |
| References | SS Virani (1268_CR1) 2020; 141 PV Thai (1268_CR16) 2020; 19 DN Vikulova (1268_CR6) 2019; 8 F Guerrero-Romero (1268_CR38) 2010; 95 B Park (1268_CR24) 2020; 19 AC Vasques (1268_CR39) 2011; 93 X Tian (1268_CR25) 2021; 20 PD Rosenblit (1268_CR3) 2019; 19 DF Stroup (1268_CR26) 2000; 283 S Beddhu (1268_CR33) 2004; 17 LL Hayman (1268_CR7) 2020; 22 ZT Bloomgarden (1268_CR11) 2006; 26 E Cersosimo (1268_CR12) 2014; 10 S Hong (1268_CR23) 2020; 18 SH Khan (1268_CR13) 2018; 10 1268_CR29 1268_CR27 LE Simental-Mendia (1268_CR28) 2008; 6 WY Su (1268_CR21) 2019; 11 L Sanchez-Inigo (1268_CR19) 2016; 46 MR Salazar (1268_CR20) 2017; 27 A Di Pino (1268_CR8) 2019; 40 EY Lee (1268_CR15) 2016; 15 D Mahtta (1268_CR5) 2020; 22 J Alizargar (1268_CR14) 2020; 19 S Barquera (1268_CR2) 2015; 46 S Li (1268_CR18) 2019; 9 S Choi (1268_CR4) 2019; 8 JK Beverly (1268_CR9) 2020; 12 KE Bornfeldt (1268_CR10) 2011; 14 M Egger (1268_CR32) 1997; 315 N Barzegar (1268_CR22) 2020; 19 NA Patsopoulos (1268_CR31) 2008; 37 AK Poon (1268_CR37) 2020; 20 W Shi (1268_CR17) 2020; 30 JP Higgins (1268_CR30) 2002; 21 VZ Rocha (1268_CR34) 2009; 6 SB Wheatcroft (1268_CR35) 2003; 20 RJ Kaaja (1268_CR36) 2006; 24 M Shahavandi (1268_CR40) 2020; 53 |
| References_xml | – volume: 22 start-page: 86 year: 2020 ident: 1268_CR7 publication-title: Curr Cardiol Rep doi: 10.1007/s11886-020-01332-y – volume: 9 start-page: 7320 year: 2019 ident: 1268_CR18 publication-title: Sci Rep doi: 10.1038/s41598-019-43776-5 – volume: 11 start-page: 2838 year: 2019 ident: 1268_CR21 publication-title: Nutrients doi: 10.3390/nu11112838 – volume: 46 start-page: 328 year: 2015 ident: 1268_CR2 publication-title: Arch Med Res doi: 10.1016/j.arcmed.2015.06.006 – volume: 19 start-page: 8 year: 2020 ident: 1268_CR14 publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-019-0982-2 – volume: 8 start-page: 173 year: 2019 ident: 1268_CR4 publication-title: J Lipid Atheroscler doi: 10.12997/jla.2019.8.2.173 – volume: 95 start-page: 3347 year: 2010 ident: 1268_CR38 publication-title: J Clin Endocrinol Metab. doi: 10.1210/jc.2010-0288 – volume: 26 start-page: vi issue: 611–33 year: 2006 ident: 1268_CR11 publication-title: Clin Lab Med – volume: 40 start-page: 1447 year: 2019 ident: 1268_CR8 publication-title: Endocr Rev doi: 10.1210/er.2018-00141 – volume: 20 start-page: 19 year: 2021 ident: 1268_CR25 publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-020-01210-5 – volume: 19 start-page: 137 year: 2020 ident: 1268_CR16 publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-020-01108-2 – volume: 15 start-page: 155 year: 2016 ident: 1268_CR15 publication-title: Lipids Health Dis doi: 10.1186/s12944-016-0324-2 – volume: 6 start-page: 299 year: 2008 ident: 1268_CR28 publication-title: Metab Syndr Relat Disord doi: 10.1089/met.2008.0034 – volume: 27 start-page: 366 year: 2017 ident: 1268_CR20 publication-title: Nutr Metab Cardiovasc Dis doi: 10.1016/j.numecd.2016.12.002 – volume: 19 start-page: 155 year: 2020 ident: 1268_CR22 publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-020-01121-5 – ident: 1268_CR27 – volume: 315 start-page: 629 year: 1997 ident: 1268_CR32 publication-title: BMJ doi: 10.1136/bmj.315.7109.629 – volume: 53 start-page: 102531 year: 2020 ident: 1268_CR40 publication-title: Complement Ther Med doi: 10.1016/j.ctim.2020.102531 – volume: 24 start-page: 131 year: 2006 ident: 1268_CR36 publication-title: J Hypertens doi: 10.1097/01.hjh.0000194121.19851.e5 – volume: 12 start-page: 102 year: 2020 ident: 1268_CR9 publication-title: J Diabetes doi: 10.1111/1753-0407.12970 – volume: 18 start-page: 361 year: 2020 ident: 1268_CR23 publication-title: BMC Med doi: 10.1186/s12916-020-01824-2 – ident: 1268_CR29 – volume: 20 start-page: 217 year: 2020 ident: 1268_CR37 publication-title: BMC Cardiovasc Disord doi: 10.1186/s12872-020-01496-z – volume: 93 start-page: e98 year: 2011 ident: 1268_CR39 publication-title: Diabetes Res Clin Pract doi: 10.1016/j.diabres.2011.05.030 – volume: 17 start-page: 229 year: 2004 ident: 1268_CR33 publication-title: Semin Dial doi: 10.1111/j.0894-0959.2004.17311.x – volume: 8 start-page: e012178 year: 2019 ident: 1268_CR6 publication-title: J Am Heart Assoc doi: 10.1161/JAHA.119.012178 – volume: 46 start-page: 189 year: 2016 ident: 1268_CR19 publication-title: Eur J Clin Invest doi: 10.1111/eci.12583 – volume: 6 start-page: 399 year: 2009 ident: 1268_CR34 publication-title: Nat Rev Cardiol doi: 10.1038/nrcardio.2009.55 – volume: 10 start-page: 2 year: 2014 ident: 1268_CR12 publication-title: Curr Diabetes Rev doi: 10.2174/1573399810666140214093600 – volume: 22 start-page: 44 year: 2020 ident: 1268_CR5 publication-title: Curr Atheroscler Rep doi: 10.1007/s11883-020-00862-8 – volume: 10 start-page: 74 year: 2018 ident: 1268_CR13 publication-title: Diabetol Metab Syndr doi: 10.1186/s13098-018-0376-8 – volume: 283 start-page: 2008 year: 2000 ident: 1268_CR26 publication-title: JAMA doi: 10.1001/jama.283.15.2008 – volume: 19 start-page: 61 year: 2019 ident: 1268_CR3 publication-title: Curr Diab Rep doi: 10.1007/s11892-019-1178-6 – volume: 30 start-page: 245 year: 2020 ident: 1268_CR17 publication-title: Nutr Metab Cardiovasc Dis doi: 10.1016/j.numecd.2019.09.015 – volume: 14 start-page: 575 year: 2011 ident: 1268_CR10 publication-title: Cell Metab doi: 10.1016/j.cmet.2011.07.015 – volume: 19 start-page: 210 year: 2020 ident: 1268_CR24 publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-020-01186-2 – volume: 21 start-page: 1539 year: 2002 ident: 1268_CR30 publication-title: Stat Med doi: 10.1002/sim.1186 – volume: 20 start-page: 255 year: 2003 ident: 1268_CR35 publication-title: Diabet Med doi: 10.1046/j.1464-5491.2003.00869.x – volume: 141 start-page: e139 year: 2020 ident: 1268_CR1 publication-title: Circulation – volume: 37 start-page: 1148 year: 2008 ident: 1268_CR31 publication-title: Int J Epidemiol doi: 10.1093/ije/dyn065 |
| SSID | ssj0017861 |
| Score | 2.6566267 |
| SecondaryResourceType | review_article |
| Snippet | Background
Insulin resistance has been demonstrated to be involved in the pathogenesis of atherosclerotic cardiovascular diseases (ASCVDs). This study... Insulin resistance has been demonstrated to be involved in the pathogenesis of atherosclerotic cardiovascular diseases (ASCVDs). This study evaluated the... Background Insulin resistance has been demonstrated to be involved in the pathogenesis of atherosclerotic cardiovascular diseases (ASCVDs). This study... Abstract Background Insulin resistance has been demonstrated to be involved in the pathogenesis of atherosclerotic cardiovascular diseases (ASCVDs). This study... |
| SourceID | doaj pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 76 |
| SubjectTerms | Age Angina pectoris Angiology Arteriosclerosis Asymmetry Atherosclerosis Atherosclerotic cardiovascular diseases Cardiology Cardiovascular disease Cardiovascular diseases Cohort analysis Coronary artery Coronary artery disease Coronary vessels Diabetes Diabetes mellitus Glucose Heart diseases Insulin Insulin resistance Medicine Medicine & Public Health Meta-analysis Original Investigation Population Risk factors Stroke Triglyceride-glucose index |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3JbtYwEB5BQYgL-xIoyEjcIKq3OAkXBIiKA1QcivTfIv9eSqWSlCRFQuLAO_CGPAljx0n1s_TCNbEjO7N94xnPADwulWGaSp1LW9FcGlOgHqyL3CmqqfAGtWXsWvK23NurVqv6fTpwG1Ja5awTo6K2nQln5Dtoh0PxdDS4z48_56FrVIiuphYa5-FCaJsd-LxcLQ4XKyvF5osyldoZgm0LUcvgQHOFgr5hjGLN_r8BzT_zJX8LmkZbtHv1f3dxDa4kFEpeTGxzHc659gZcepfi7Dfh2z7OOfpqkD2t-_n9R0psJ7G2ItGtJYgbSTimjy1JSedJRJLdgJ_rO_wqMRuJriQFgoZnRJNPbtS5TtVQwtzQpbcfyTDlNN6CD7uv91-9yVOfhtyoUoz52qw5lY5b9Oe8sOgSIW6wvNLUO-5daRFWMeVthV486guruLSF1WsnK8kt4qfbsNV2rbsLxHIvVF1wBE5eeks114horUCY5xkrTQZsJlhjUhHz0EvjqInOTKWaicgNErmJRG7qDJ4sc46nEh5njn4Z-GAZGcpvxwddf9Akacaxxitn0NVF7xi3qS3D_Yvar5mhRWEz2J7J3ySdMDSntM_g0fIapTmEaHTrupMwBrU-Oj1CZnBnYrplJQLBFRelyKDcYMeNpW6-aQ8_xorhVbgWSlkGT2fGPV3Wv3_FvbN3cR8u8yhLMqdiG7bG_sQ9gIvmy3g49A-jJP4C0Vo9Gw priority: 102 providerName: ProQuest – databaseName: SpringerLINK Contemporary 1997-Present dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Ni9YwEB50FfHi90d1lQjetJgmaZp6U3HxoIvoKnsrefOhC2srbVcQPPgf_If-EidpWqmugl7bSUnTmcnzdCYzAHcraQpNhc6FVTQXxpToB-syd5Jqyr1Bbxm7ljyvdnfV_n79Mh0KG-Zs9zkkGT11NGslHwxhZwoxx0B_mUQzPQmncLtToWHDq9dvl9hBpWQxH485dtxqC4qV-o-Dl79nSf4SKo070M75_5v7BTiXECd5NKnIRTjh2ktw5kWKqV-GL3tI0A8_G1RF675__ZaS2Emso0h0awliRBJ-ycf2o6TzJKLGbsDH9R0-lZhVUitJQZ_hIdHkgxt1rlPlkzA2dOTtRzJM-YtX4M3O070nz_LUkyE3suJjvjEbRoVjFrmb5xbpD2IEy5Sm3jHvKosQqpDeKmTs6BusZMKWVm-cUIJZxEpXYavtWncdiGWey7pkCJK88JZqphG9Wo6QzhdFZTIo5s_UmFSwPPTNOGwicVGymZa1wWVt4rI2dQb3ljEfp3Idf5V-HL7-IhlKbccLXf-uSZaLssZLZ5DWIhPG19S2wPfntd8UhpalzWB71p0m2f_QIGoMpf4RHmZwZ7mNlhvCMbp13VGQQQ-PBIeLDK5NqrbMhCOQYrziGVQrJVxNdX2nPXgfq4OrcASUFhncn1Xx57T-vBQ3_k38JpxlUZtFTvk2bI39kbsFp82n8WDob0d7_AHJmzNc priority: 102 providerName: Springer Nature |
| Title | Triglyceride–glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies |
| URI | https://link.springer.com/article/10.1186/s12933-021-01268-9 https://www.ncbi.nlm.nih.gov/pubmed/33812373 https://www.proquest.com/docview/2514262617 https://www.proquest.com/docview/2508888234 https://pubmed.ncbi.nlm.nih.gov/PMC8019501 https://doaj.org/article/01cf6ec917094a0fad14e239fb1c055d |
| Volume | 20 |
| WOSCitedRecordID | wos000636718400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMedCentral customDbUrl: eissn: 1475-2840 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017861 issn: 1475-2840 databaseCode: RBZ dateStart: 20020101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1475-2840 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017861 issn: 1475-2840 databaseCode: DOA dateStart: 20020101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1475-2840 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017861 issn: 1475-2840 databaseCode: M~E dateStart: 20020101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1475-2840 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017861 issn: 1475-2840 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1475-2840 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017861 issn: 1475-2840 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1475-2840 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017861 issn: 1475-2840 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1475-2840 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017861 issn: 1475-2840 databaseCode: RSV dateStart: 20021201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bi9UwEB50FfFFvFtdDxF807K5tEnrmyu7KLiHw7rK8ank5MIurK2cdgXBB_-D_9Bf4iRtj9briy-FtkkJk5nk-zqTGYCHShqmaabTzBY0zYzJcR0s89RJqqnwBlfLWLXkpZrPi-WyXPxQ6ivEhPXpgXvB7VBmvHQGWQUSEU29tixzXJR-xQzNcxtWX6rKkUwN_gNVSDYekSnkTht2teCvDNSZSzTxyTYUs_X_DmL-Gin5k7s07kL7V-HKAB_J037Y1-Ccq6_DpYPBQX4DPh0h2z79aFCvrPv6-csQkU5iUkSia0sQ8JHwfz3WEiWNJxECNi1-bt3gV4mZRKiSwYPTPiGavHOdTvWQxiT0DeV11x1p-2DEm_B6f-_o2fN0KLCQGqlEl67MilOUpkUi5oVFLoMbvuUFitlx75RFPMSktwXSbzR0K3lmc6tXLisybhH43IKtuqndHSCWeyHLnCPi8Zm3VHONUNQKxGeeMWUSYKO8KzNkHw9FME6ryEIKWfVzVOEcVXGOqjKBR5s-7_vcG39tvRumcdMy5M2OD1CbqkGbqn9pUwLboxJUgzG3FULAkLcfsV4CDzav0QyDb0XXrjkLbXC5RrYisgRu9zqzGYlAVMSFEgmoiTZNhjp9U58cx1TfRTjPSVkCj0e9-z6sP4vi7v8QxT24zKPBZCkV27DVrc_cfbhoPnQn7XoG59VSxWsxgwu7e_PF4SyaIN4tXhws3uLd4as33wAk0DXD |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3LbtUwEB2VgoAN70eggJFgBVEdO3ESJIR4Va16e8XiIt1d8PUDKpWkJCmoEgv-gf_go_gSxs6jujy664Jt4lh2cmbmTGY8A_AgFSqSNJZhrDMaxkolqAfzJDSCSsqtQm3pu5ZM0uk0m8_zNyvwYzgL49IqB53oFbWulPtHvo522BVPR4P7bP9T6LpGuejq0EKjg8W2OfyCLlvzdOsVft-HjG28nr3cDPuuAqESKW_DhVowGhum0fuwXCOBRyunWSapNcyaVCMJiITVGfqciG4tWKwTLRcmzmKm0drjvKfgNOrx1Dl76Xx08KI0E9FwMCcT642zpS5K6hx2JlCxLBk_3yPgb8T2z_zM34K03vZtXPzf3toluNCzbPK8E4vLsGLKK3B2p88juApfZ7jGvUOF4qfNz2_f-8R94mtHEllqgryYuDCEb7lKKks8U64anK6ucFailhJ5SR_oap4QST6aVoayr_binnVdiOuWNF3O5jV4eyJ7vw6rZVWam0A0s1zkCUNiaGOrqWQSGbvmSGNtFKUqgGgASKH6Iu2uV8he4Z21TBQdqAoEVeFBVeQBPBqf2e9KlBw7-oXD3TjSlRf3F6r6fdFrKxyrrDAKXXn0_nGbUke4f57bRaRokugA1ga4Fb3Oa4ojrAVwf7yN2sqFoGRpqgM3Bq0aOnU8DuBGB_JxJRzJI-MpDyBdgv_SUpfvlLsffEX0zB17pVEAjwdBOVrWv1_FreN3cQ_Obc52JsVka7p9G84zL8dxSPkarLb1gbkDZ9Tndrep73otQODdSQvQL4xXmkE |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LbtUwEB1BQRWb8iwEChiJHUR1bMdJ2PG6AlGuKlFQd5GvH1CpJFWSVkJiwT_wh3wJY-cBgYKE2N6MI9t3ZnxOZjwDcD-TOlFUqFiYnMZC6xT9YJHGVlJFudPoLUPXkp1sucz394vdn27xh2z3MSTZ32nwVZqqbvvIuN7Ec7nd-lPKxx89FWYSTfYsnBM-kd7z9TfvpjhClstkvCpz6rjZcRSq9p8GNX_PmPwlbBpOo8XF_1_HJdgYkCh53KvOZThjqyuw_nqItV-Fz3tI3A8_aVRRY799-Tokt5NQX5GoyhDEjsR_qg9tSUntSECTdYuva2p8K9GzZFcyBIPaR0SRj7ZTsRoqovixvlNv05G2z2u8Bm8Xz_eevoiHXg2xlhnv4pVeMSosM8jpHDdIixA7GJYr6ixzNjMIrRLpTI5MHn2GkUyY1KiVFblgBjHUJqxVdWVvADHMcVmkDMGTE85QxRSiWsMR6rkkyXQEyfiXlXooZO77aRyWgdDksuy3tcRtLcO2lkUED6YxR30Zj79KP_GaMEn6Etzhh7p5Xw4WjbLaSauR7iJDxmUqk-D6eeFWiaZpaiLYGvWoHPxCWyKa9C0AEDZGcG96jBbtwzSqsvWxl0HPj8SHiwiu92o3zYQjwGI84xFkM4WcTXX-pDr4EKqG5_5qKE0ieDiq5Y9p_Xkrbv6b-F1Y3322KHdeLl_dggssKLaIKd-Cta45trfhvD7pDtrmTjDT7xu-PyQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Triglyceride%E2%80%93glucose+index+and+the+incidence+of+atherosclerotic+cardiovascular+diseases%3A+a+meta-analysis+of+cohort+studies&rft.jtitle=Cardiovascular+diabetology&rft.au=Ding%2C+Xiaobo&rft.au=Wang%2C+Xiaozhen&rft.au=Wu%2C+Jing&rft.au=Zhang%2C+Manli&rft.date=2021-04-03&rft.pub=BioMed+Central&rft.eissn=1475-2840&rft.volume=20&rft_id=info:doi/10.1186%2Fs12933-021-01268-9&rft_id=info%3Apmid%2F33812373&rft.externalDocID=PMC8019501 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1475-2840&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1475-2840&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1475-2840&client=summon |